LISATA THERAPEUTICS, INC. Debt Securities, Available-for-sale
LISATA THERAPEUTICS, INC. (LSTA) had Debt Securities, Available-for-sale of $8.83 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale $8.83M.
- 2026-03-31: Debt Securities, Available-for-sale $8.75M.
- 2025-12-31: Debt Securities, Available-for-sale $11.64M.
- 2025-09-30: Debt Securities, Available-for-sale $14.49M.
| Period end | Debt Securities, Available-for-sale | Debt Securities, Available-for-sale as first filed |
|---|---|---|
| 2026-06-30 | $8.83M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $8.75M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $11.64M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $14.49M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $17.25M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $22.98M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $25.65M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $30.30M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $33.83M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $39.22M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $44.66M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $51.07M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $53.41M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $55.58M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $64.74M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $67.33M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $69.69M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $86.42M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $91.45M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $96.98M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $102.21M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $106.92M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $30.74M 10-K · filed 2022-03-22 | |
| 2020-09-30 | $37.78M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $32.61M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $17.04M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $22.77M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $26.69M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $30.75M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $36.12M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $37.82M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $40.70M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $39.98M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $42.27M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $51.88M 10-K · filed 2019-03-14 | $51.88M 10-K · filed 2018-03-22 |
| 2017-09-30 | $56.24M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $55.77M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.43M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.43M 10-Q · filed 2017-11-09 | |
| 2016-09-30 | $4.39M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $8.29M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.41M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $6.88M 10-K · filed 2016-03-15 | |
| 2015-09-30 | $18.42M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $28.32M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $14.51M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $22.36M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $18.48M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $28.38M 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |